Structure Therapeutics Inc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Structure Therapeutics Inc - ADR: Is Infosys Ltd. worth buying?
Item: Structure Therapeutics Inc - ADR
Rating: 1.65400
Author: Trendlyne DVM scores

about

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both struc...

25.63 1.62 (6.75%)

43.28% Fall from 52W High

1.0M

XNAS Volume

XNAS 24 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.0 / 100

Technically Neutral

57.2 / 100

No estimates available

Structure Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Structure Therapeutics Inc - ADR Live Stock Price Today, Share Analysis and Chart

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both struc...

43.28% Fall from 52W High

SWOT Analysis

Structure Therapeutics Inc Live Price Chart